Stay updated on INCAGN01876 Combo Immune Therapies Clinical Trial
Sign up to get notified when there's something new on the INCAGN01876 Combo Immune Therapies Clinical Trial page.

Latest updates to the INCAGN01876 Combo Immune Therapies Clinical Trial page
- Check6 days agoChange DetectedThe study record has been updated to revision v3.5.3, replacing the previous v3.5.2. This indicates a new revision of the study documentation.SummaryDifference0.0%

- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedRevision label updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check27 days agoNo Change Detected
- Check34 days agoChange DetectedAdded keywords/MeSH terms: Small cell lung carcinoma and Cutaneous neuroendocrine carcinoma.SummaryDifference0.1%

- Check49 days agoChange DetectedAdded Hepatocellular carcinoma to the keywords and updated the revision history to v3.5.0 (replacing v3.4.3).SummaryDifference0.1%

- Check56 days agoChange DetectedRevision: v3.4.3 added and revision v3.4.2 removed. This appears to be a metadata/version update with no observed changes to the study details.SummaryDifference0.0%

- Check77 days agoChange DetectedAdded 'Gastric cancer' as a keyword/MeSH term to the study page to improve indexing and searchability. No changes to the study design, eligibility criteria, or outcomes.SummaryDifference0.0%

Stay in the know with updates to INCAGN01876 Combo Immune Therapies Clinical Trial
Enter your email address, and we'll notify you when there's something new on the INCAGN01876 Combo Immune Therapies Clinical Trial page.